19th April 2024
Professor Tom Powles and team reveal first successful adjuvant therapy for kidney cancer in 50 years.
Read more27th February 2024
Experts in the field converged to discuss the latest advances in pancreatic cancer
Read more25th October 2023
Clinical trial results from BCI and Barts NHS trust provide new hope for people with bladder cancer.
Read more29th June 2023
Experts in the field converged to discuss the latest advances in pancreatic cancer
Read more16th April 2023
An innovative therapy provides new hope to patients with malignant mesothelioma – a rare but rapidly fatal type of cancer with few effective treatment options – according to results presented by Professor Peter Szlosarek and his team at Barts Cancer Institute, Queen Mary University of London.
Read more11th November 2021
Research conducted at Barts Cancer Institute (BCI), Queen Mary University of London, indicates that regular blood tests before and during chemotherapy for prostate cancer can detect whether or not a patient is resistant or developing resistance to treatment with a drug called docetaxel. Ms Caitlin Davies, a PhD student at BCI, presented the findings from her PhD research at the National Cancer Research Institute (NCRI) Festival, which is taking place from 8-12th November 2021.
Read more